Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris.
ADAM10 Protein
/ immunology
ADAM17 Protein
/ immunology
Amyloid Precursor Protein Secretases
Animals
Autoantibodies
/ immunology
Cell Adhesion
/ immunology
Desmoglein 1
/ immunology
Desmoglein 3
/ immunology
Humans
Immunoglobulin G
/ immunology
Keratinocytes
/ immunology
Membrane Proteins
/ metabolism
Mice
Pemphigus
/ immunology
a disintegrin and metalloproteinase 10 (ADAM10)
a disintegrin and metalloproteinase 17 (ADAM17)
cell cohesion
desmoglein 3 (Dsg3)
hyperadhesion
pemphigus vulgaris (PV)
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
02
2022
accepted:
26
04
2022
entrez:
18
7
2022
pubmed:
19
7
2022
medline:
20
7
2022
Statut:
epublish
Résumé
The severe autoimmune blistering disease Pemphigus vulgaris (PV) is mainly caused by autoantibodies (IgG) against desmoglein (Dsg) 3 and Dsg1. The mechanisms leading to the development of blisters are not fully understood, but intracellular signaling seems to play an important role. Sheddases ADAM10 and ADAM17 are involved in the turnover of the desmosomal cadherin Dsg2 and ADAM10 has been shown to contribute to acantholysis in a murine pemphigus model. In the present study, we further examined the role of ADAM10 and ADAM17 both in keratinocyte adhesion and in the pathogenesis of PV. First, we found that inhibition of ADAM10 enhanced adhesion of primary human keratinocytes but not of immortalized keratinocytes. In dissociation assays, inhibition of ADAM10 shifted keratinocyte adhesion towards a hyperadhesive state. However, ADAM inhibition did neither modulate protein levels of Dsg1 and Dsg3 nor activation of EGFR at Y1068 and Y845. In primary human keratinocytes, inhibition of ADAM10, but not ADAM17, reduced loss of cell adhesion and fragmentation of Dsg1 and Dsg3 immunostaining in response to a PV1-IgG from a mucocutaneous PV patient. Similarly, inhibition of ADAM10 in dissociation assay decreased fragmentation of primary keratinocytes induced by a monoclonal antibody against Dsg3 and by PV-IgG from two other patients both suffering from mucosal PV. However, such protective effect was not observed in both cultured cells and
Identifiants
pubmed: 35844545
doi: 10.3389/fimmu.2022.884248
pmc: PMC9279611
doi:
Substances chimiques
Autoantibodies
0
Desmoglein 1
0
Desmoglein 3
0
Immunoglobulin G
0
Membrane Proteins
0
Amyloid Precursor Protein Secretases
EC 3.4.-
ADAM10 Protein
EC 3.4.24.81
ADAM10 protein, human
EC 3.4.24.81
Adam10 protein, mouse
EC 3.4.24.81
ADAM17 Protein
EC 3.4.24.86
ADAM17 protein, human
EC 3.4.24.86
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
884248Informations de copyright
Copyright © 2022 Kugelmann, Anders, Sigmund, Egu, Eichkorn, Yazdi, Sárdy, Hertl, Didona, Hashimoto and Waschke.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Semin Cell Dev Biol. 2009 Apr;20(2):126-37
pubmed: 19049889
J Biol Chem. 2009 Aug 28;284(35):23386-96
pubmed: 19574220
J Invest Dermatol. 2011 Mar;131(3):706-18
pubmed: 21160493
Front Mol Neurosci. 2017 Mar 17;10:56
pubmed: 28367112
J Clin Invest. 2005 Nov;115(11):3157-65
pubmed: 16211092
Biophys J. 2020 Oct 20;119(8):1489-1500
pubmed: 33031738
Biomolecules. 2021 Oct 13;11(10):
pubmed: 34680139
Mol Aspects Med. 2008 Oct;29(5):258-89
pubmed: 18762209
J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):167-70
pubmed: 10025740
Mol Biol Cell. 2015 Sep 15;26(18):3165-77
pubmed: 26224314
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2071-2081
pubmed: 28624438
J Biol Chem. 2006 Aug 18;281(33):23824-9
pubmed: 16777847
Pediatr Dermatol. 2020 Jan;37(1):241-243
pubmed: 31774569
Front Immunol. 2019 Apr 04;10:626
pubmed: 31024527
J Biol Chem. 2014 Jun 13;289(24):17043-53
pubmed: 24782306
J Anat. 2022 Feb 6;:
pubmed: 35128661
J Immunol. 2003 Feb 15;170(4):2170-8
pubmed: 12574390
Biochem Soc Trans. 2008 Apr;36(Pt 2):195-201
pubmed: 18363561
Front Med (Lausanne). 2021 Aug 09;8:701809
pubmed: 34434944
PLoS One. 2012;7(12):e50696
pubmed: 23226536
Curr Opin Cell Biol. 2003 Oct;15(5):598-606
pubmed: 14519395
Am J Pathol. 2014 Sep;184(9):2528-36
pubmed: 25010392
Br J Dermatol. 2021 Sep;185(3):595-604
pubmed: 33792909
Autoimmunity. 2014 Mar;47(2):134-40
pubmed: 24328683
PLoS One. 2013;8(1):e53739
pubmed: 23326495
Cell Commun Adhes. 2014 Oct;21(5):249-56
pubmed: 24978153
Front Immunol. 2018 Feb 01;9:136
pubmed: 29449846
J Invest Dermatol. 2012 Feb;132(2):482-5
pubmed: 21993560
Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):
pubmed: 28096266
Sci Rep. 2017 Jun 15;7(1):3579
pubmed: 28620161
J Invest Dermatol. 2013 Feb;133(2):576-7
pubmed: 22931924
Br J Dermatol. 2020 Apr;182(4):987-994
pubmed: 31218663
J Clin Invest. 2013 Feb;123(2):800-11
pubmed: 23298835
J Cell Biol. 2004 Mar 1;164(5):769-79
pubmed: 14993236
Dermatol Res Pract. 2010;2010:212439
pubmed: 20671997
Circ Res. 2017 Apr 14;120(8):1305-1317
pubmed: 28289018
J Invest Dermatol. 2019 Jul;139(7):1596-1599.e2
pubmed: 30660666
J Biol Chem. 2007 May 4;282(18):13804-12
pubmed: 17344213
Mol Cell Biol. 2006 Jul;26(13):5086-95
pubmed: 16782893
Front Immunol. 2019 May 24;10:1128
pubmed: 31178865
Biochim Biophys Acta. 2008 Mar;1778(3):572-87
pubmed: 17854763
Exp Dermatol. 2022 Feb;31(2):154-171
pubmed: 34435386
J Clin Invest. 2022 Feb 1;132(3):
pubmed: 34905516
J Cell Biol. 2020 Jun 1;219(6):
pubmed: 32399559
Histochem Cell Biol. 2008 Jul;130(1):21-54
pubmed: 18386043
Am J Pathol. 2007 Sep;171(3):906-16
pubmed: 17640963
Mol Biol Cell. 2009 Jan;20(1):328-37
pubmed: 18987342
N Engl J Med. 2011 Oct 20;365(16):1502-8
pubmed: 22010916
Ann Anat. 2022 Apr;241:151904
pubmed: 35131450
J Biol Chem. 2006 Mar 17;281(11):7623-34
pubmed: 16377623
Br J Dermatol. 2020 May;182(5):1194-1204
pubmed: 31370093
J Cell Sci. 2005 Dec 15;118(Pt 24):5743-54
pubmed: 16303847
Exp Cell Res. 2010 Feb 15;316(4):580-92
pubmed: 19818770
Nat Rev Dis Primers. 2017 May 11;3:17026
pubmed: 28492232
Br J Dermatol. 2005 May;152(5):915-9
pubmed: 15888146
Br J Dermatol. 2017 Dec;177(6):1612-1618
pubmed: 28600798
Br J Dermatol. 2008 Jun;158(6):1371-3
pubmed: 18363768
J Invest Dermatol. 2008 Jul;128(7):1737-46
pubmed: 18200054
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2082-2087
pubmed: 28624437